StockData
UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

UTAH MEDICAL PRODUCTS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$74.55+0.04 (+0.05%)

Close on Oct 19, 2026

Market cap
$237.37M
P/E (TTM)
22.7
Dividend yield
–

UTAH MEDICAL PRODUCTS INC revenue by segment

No segment breakdown reported

Utah Medical Products does not break out revenue by segment, region or product in the tagged data of its filings for this period type.